nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—Malnutrition—Docetaxel—pancreatic cancer	0.000756	0.000756	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Gemcitabine—pancreatic cancer	0.000756	0.000756	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Fluorouracil—pancreatic cancer	0.000753	0.000753	CcSEcCtD
Fondaparinux sodium—Nausea—Tamoxifen—pancreatic cancer	0.000752	0.000752	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000751	0.000751	CcSEcCtD
Fondaparinux sodium—Fatigue—Gemcitabine—pancreatic cancer	0.00075	0.00075	CcSEcCtD
Fondaparinux sodium—Gastritis—Epirubicin—pancreatic cancer	0.00075	0.00075	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000747	0.000747	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000745	0.000745	CcSEcCtD
Fondaparinux sodium—Pain—Gemcitabine—pancreatic cancer	0.000744	0.000744	CcSEcCtD
Fondaparinux sodium—Constipation—Gemcitabine—pancreatic cancer	0.000744	0.000744	CcSEcCtD
Fondaparinux sodium—Nausea—Erlotinib—pancreatic cancer	0.000744	0.000744	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Fluorouracil—pancreatic cancer	0.000743	0.000743	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Sunitinib—pancreatic cancer	0.000742	0.000742	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Docetaxel—pancreatic cancer	0.00074	0.00074	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000738	0.000738	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Epirubicin—pancreatic cancer	0.000737	0.000737	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Irinotecan—pancreatic cancer	0.000736	0.000736	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000734	0.000734	CcSEcCtD
Fondaparinux sodium—Dysphagia—Epirubicin—pancreatic cancer	0.000732	0.000732	CcSEcCtD
Fondaparinux sodium—Back pain—Docetaxel—pancreatic cancer	0.000731	0.000731	CcSEcCtD
Fondaparinux sodium—Pain—Fluorouracil—pancreatic cancer	0.000731	0.000731	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00073	0.00073	CcSEcCtD
Fondaparinux sodium—Dehydration—Doxorubicin—pancreatic cancer	0.000729	0.000729	CcSEcCtD
Fondaparinux sodium—Dizziness—Sunitinib—pancreatic cancer	0.000717	0.000717	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000717	0.000717	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000713	0.000713	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Irinotecan—pancreatic cancer	0.000706	0.000706	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Irinotecan—pancreatic cancer	0.000706	0.000706	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000706	0.000706	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000705	0.000705	CcSEcCtD
Fondaparinux sodium—Bronchitis—Epirubicin—pancreatic cancer	0.000704	0.000704	CcSEcCtD
Fondaparinux sodium—Anaemia—Docetaxel—pancreatic cancer	0.000699	0.000699	CcSEcCtD
Fondaparinux sodium—Gastritis—Doxorubicin—pancreatic cancer	0.000694	0.000694	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000691	0.000691	CcSEcCtD
Fondaparinux sodium—Vomiting—Sunitinib—pancreatic cancer	0.000689	0.000689	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Gemcitabine—pancreatic cancer	0.000687	0.000687	CcSEcCtD
Fondaparinux sodium—Rash—Sunitinib—pancreatic cancer	0.000683	0.000683	CcSEcCtD
Fondaparinux sodium—Dermatitis—Sunitinib—pancreatic cancer	0.000683	0.000683	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Doxorubicin—pancreatic cancer	0.000682	0.000682	CcSEcCtD
Fondaparinux sodium—Urticaria—Fluorouracil—pancreatic cancer	0.000679	0.000679	CcSEcCtD
Fondaparinux sodium—Headache—Sunitinib—pancreatic cancer	0.000679	0.000679	CcSEcCtD
Fondaparinux sodium—Syncope—Docetaxel—pancreatic cancer	0.000678	0.000678	CcSEcCtD
Fondaparinux sodium—Dysphagia—Doxorubicin—pancreatic cancer	0.000677	0.000677	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Fluorouracil—pancreatic cancer	0.000676	0.000676	CcSEcCtD
Fondaparinux sodium—Palpitations—Docetaxel—pancreatic cancer	0.000668	0.000668	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Docetaxel—pancreatic cancer	0.000665	0.000665	CcSEcCtD
Fondaparinux sodium—Cough—Docetaxel—pancreatic cancer	0.00066	0.00066	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Irinotecan—pancreatic cancer	0.000658	0.000658	CcSEcCtD
Fondaparinux sodium—Convulsion—Docetaxel—pancreatic cancer	0.000655	0.000655	CcSEcCtD
Fondaparinux sodium—Infestation—Epirubicin—pancreatic cancer	0.000653	0.000653	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Epirubicin—pancreatic cancer	0.000653	0.000653	CcSEcCtD
Fondaparinux sodium—Bronchitis—Doxorubicin—pancreatic cancer	0.000651	0.000651	CcSEcCtD
Fondaparinux sodium—Chest pain—Docetaxel—pancreatic cancer	0.000644	0.000644	CcSEcCtD
Fondaparinux sodium—Nausea—Sunitinib—pancreatic cancer	0.000644	0.000644	CcSEcCtD
Fondaparinux sodium—Renal failure—Epirubicin—pancreatic cancer	0.000642	0.000642	CcSEcCtD
Fondaparinux sodium—Asthenia—Irinotecan—pancreatic cancer	0.000641	0.000641	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000639	0.000639	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Epirubicin—pancreatic cancer	0.000634	0.000634	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00063	0.00063	CcSEcCtD
Fondaparinux sodium—Asthenia—Gemcitabine—pancreatic cancer	0.000624	0.000624	CcSEcCtD
Fondaparinux sodium—Haematuria—Epirubicin—pancreatic cancer	0.000622	0.000622	CcSEcCtD
Fondaparinux sodium—Confusional state—Docetaxel—pancreatic cancer	0.000622	0.000622	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000617	0.000617	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000617	0.000617	CcSEcCtD
Fondaparinux sodium—Oedema—Docetaxel—pancreatic cancer	0.000617	0.000617	CcSEcCtD
Fondaparinux sodium—Epistaxis—Epirubicin—pancreatic cancer	0.000616	0.000616	CcSEcCtD
Fondaparinux sodium—Pruritus—Gemcitabine—pancreatic cancer	0.000615	0.000615	CcSEcCtD
Fondaparinux sodium—Infection—Docetaxel—pancreatic cancer	0.000613	0.000613	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Irinotecan—pancreatic cancer	0.000611	0.000611	CcSEcCtD
Fondaparinux sodium—Shock—Docetaxel—pancreatic cancer	0.000607	0.000607	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Docetaxel—pancreatic cancer	0.000605	0.000605	CcSEcCtD
Fondaparinux sodium—Pruritus—Fluorouracil—pancreatic cancer	0.000605	0.000605	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000604	0.000604	CcSEcCtD
Fondaparinux sodium—Infestation—Doxorubicin—pancreatic cancer	0.000604	0.000604	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Doxorubicin—pancreatic cancer	0.000604	0.000604	CcSEcCtD
Fondaparinux sodium—Tachycardia—Docetaxel—pancreatic cancer	0.000602	0.000602	CcSEcCtD
Fondaparinux sodium—Skin disorder—Docetaxel—pancreatic cancer	0.000599	0.000599	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Gemcitabine—pancreatic cancer	0.000595	0.000595	CcSEcCtD
Fondaparinux sodium—Renal failure—Doxorubicin—pancreatic cancer	0.000594	0.000594	CcSEcCtD
Fondaparinux sodium—Dizziness—Irinotecan—pancreatic cancer	0.00059	0.00059	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Epirubicin—pancreatic cancer	0.000589	0.000589	CcSEcCtD
Fondaparinux sodium—Anorexia—Docetaxel—pancreatic cancer	0.000588	0.000588	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000587	0.000587	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Epirubicin—pancreatic cancer	0.000586	0.000586	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Fluorouracil—pancreatic cancer	0.000585	0.000585	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000583	0.000583	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Epirubicin—pancreatic cancer	0.000577	0.000577	CcSEcCtD
Fondaparinux sodium—Hypotension—Docetaxel—pancreatic cancer	0.000577	0.000577	CcSEcCtD
Fondaparinux sodium—Haematuria—Doxorubicin—pancreatic cancer	0.000576	0.000576	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000571	0.000571	CcSEcCtD
Fondaparinux sodium—Epistaxis—Doxorubicin—pancreatic cancer	0.00057	0.00057	CcSEcCtD
Fondaparinux sodium—Vomiting—Irinotecan—pancreatic cancer	0.000568	0.000568	CcSEcCtD
Fondaparinux sodium—Dizziness—Fluorouracil—pancreatic cancer	0.000565	0.000565	CcSEcCtD
Fondaparinux sodium—Rash—Irinotecan—pancreatic cancer	0.000563	0.000563	CcSEcCtD
Fondaparinux sodium—Dermatitis—Irinotecan—pancreatic cancer	0.000562	0.000562	CcSEcCtD
Fondaparinux sodium—Headache—Irinotecan—pancreatic cancer	0.000559	0.000559	CcSEcCtD
Fondaparinux sodium—Insomnia—Docetaxel—pancreatic cancer	0.000558	0.000558	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Docetaxel—pancreatic cancer	0.000554	0.000554	CcSEcCtD
Fondaparinux sodium—Vomiting—Gemcitabine—pancreatic cancer	0.000553	0.000553	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Docetaxel—pancreatic cancer	0.00055	0.00055	CcSEcCtD
Fondaparinux sodium—Somnolence—Docetaxel—pancreatic cancer	0.000549	0.000549	CcSEcCtD
Fondaparinux sodium—Rash—Gemcitabine—pancreatic cancer	0.000548	0.000548	CcSEcCtD
Fondaparinux sodium—Dermatitis—Gemcitabine—pancreatic cancer	0.000548	0.000548	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Doxorubicin—pancreatic cancer	0.000545	0.000545	CcSEcCtD
Fondaparinux sodium—Headache—Gemcitabine—pancreatic cancer	0.000545	0.000545	CcSEcCtD
Fondaparinux sodium—Flushing—Epirubicin—pancreatic cancer	0.000544	0.000544	CcSEcCtD
Fondaparinux sodium—Vomiting—Fluorouracil—pancreatic cancer	0.000544	0.000544	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Docetaxel—pancreatic cancer	0.000543	0.000543	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Doxorubicin—pancreatic cancer	0.000542	0.000542	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000539	0.000539	CcSEcCtD
Fondaparinux sodium—Rash—Fluorouracil—pancreatic cancer	0.000539	0.000539	CcSEcCtD
Fondaparinux sodium—Dermatitis—Fluorouracil—pancreatic cancer	0.000539	0.000539	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Docetaxel—pancreatic cancer	0.000536	0.000536	CcSEcCtD
Fondaparinux sodium—Headache—Fluorouracil—pancreatic cancer	0.000536	0.000536	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000534	0.000534	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000533	0.000533	CcSEcCtD
Fondaparinux sodium—Fatigue—Docetaxel—pancreatic cancer	0.000532	0.000532	CcSEcCtD
Fondaparinux sodium—Angiopathy—Epirubicin—pancreatic cancer	0.000532	0.000532	CcSEcCtD
Fondaparinux sodium—Nausea—Irinotecan—pancreatic cancer	0.00053	0.00053	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Epirubicin—pancreatic cancer	0.000529	0.000529	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000528	0.000528	CcSEcCtD
Fondaparinux sodium—Constipation—Docetaxel—pancreatic cancer	0.000528	0.000528	CcSEcCtD
Fondaparinux sodium—Pain—Docetaxel—pancreatic cancer	0.000528	0.000528	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Epirubicin—pancreatic cancer	0.000523	0.000523	CcSEcCtD
Fondaparinux sodium—Nausea—Gemcitabine—pancreatic cancer	0.000517	0.000517	CcSEcCtD
Fondaparinux sodium—Malnutrition—Epirubicin—pancreatic cancer	0.00051	0.00051	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Docetaxel—pancreatic cancer	0.000509	0.000509	CcSEcCtD
Fondaparinux sodium—Nausea—Fluorouracil—pancreatic cancer	0.000508	0.000508	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000505	0.000505	CcSEcCtD
Fondaparinux sodium—Flushing—Doxorubicin—pancreatic cancer	0.000503	0.000503	CcSEcCtD
Fondaparinux sodium—Flatulence—Epirubicin—pancreatic cancer	0.000503	0.000503	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Epirubicin—pancreatic cancer	0.000499	0.000499	CcSEcCtD
Fondaparinux sodium—Back pain—Epirubicin—pancreatic cancer	0.000493	0.000493	CcSEcCtD
Fondaparinux sodium—Angiopathy—Doxorubicin—pancreatic cancer	0.000492	0.000492	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Doxorubicin—pancreatic cancer	0.00049	0.00049	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000489	0.000489	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Docetaxel—pancreatic cancer	0.000488	0.000488	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Docetaxel—pancreatic cancer	0.000488	0.000488	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Doxorubicin—pancreatic cancer	0.000484	0.000484	CcSEcCtD
Fondaparinux sodium—Vision blurred—Epirubicin—pancreatic cancer	0.000481	0.000481	CcSEcCtD
Fondaparinux sodium—Malnutrition—Doxorubicin—pancreatic cancer	0.000472	0.000472	CcSEcCtD
Fondaparinux sodium—Anaemia—Epirubicin—pancreatic cancer	0.000471	0.000471	CcSEcCtD
Fondaparinux sodium—Flatulence—Doxorubicin—pancreatic cancer	0.000465	0.000465	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Doxorubicin—pancreatic cancer	0.000462	0.000462	CcSEcCtD
Fondaparinux sodium—Vertigo—Epirubicin—pancreatic cancer	0.000458	0.000458	CcSEcCtD
Fondaparinux sodium—Syncope—Epirubicin—pancreatic cancer	0.000457	0.000457	CcSEcCtD
Fondaparinux sodium—Back pain—Doxorubicin—pancreatic cancer	0.000456	0.000456	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Docetaxel—pancreatic cancer	0.000455	0.000455	CcSEcCtD
Fondaparinux sodium—Palpitations—Epirubicin—pancreatic cancer	0.000451	0.000451	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Epirubicin—pancreatic cancer	0.000448	0.000448	CcSEcCtD
Fondaparinux sodium—Cough—Epirubicin—pancreatic cancer	0.000445	0.000445	CcSEcCtD
Fondaparinux sodium—Vision blurred—Doxorubicin—pancreatic cancer	0.000445	0.000445	CcSEcCtD
Fondaparinux sodium—Asthenia—Docetaxel—pancreatic cancer	0.000443	0.000443	CcSEcCtD
Fondaparinux sodium—Convulsion—Epirubicin—pancreatic cancer	0.000442	0.000442	CcSEcCtD
Fondaparinux sodium—Pruritus—Docetaxel—pancreatic cancer	0.000437	0.000437	CcSEcCtD
Fondaparinux sodium—Anaemia—Doxorubicin—pancreatic cancer	0.000436	0.000436	CcSEcCtD
Fondaparinux sodium—Chest pain—Epirubicin—pancreatic cancer	0.000434	0.000434	CcSEcCtD
Fondaparinux sodium—Anxiety—Epirubicin—pancreatic cancer	0.000433	0.000433	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000431	0.000431	CcSEcCtD
Fondaparinux sodium—Vertigo—Doxorubicin—pancreatic cancer	0.000424	0.000424	CcSEcCtD
Fondaparinux sodium—Syncope—Doxorubicin—pancreatic cancer	0.000423	0.000423	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Docetaxel—pancreatic cancer	0.000422	0.000422	CcSEcCtD
Fondaparinux sodium—Confusional state—Epirubicin—pancreatic cancer	0.00042	0.00042	CcSEcCtD
Fondaparinux sodium—Palpitations—Doxorubicin—pancreatic cancer	0.000417	0.000417	CcSEcCtD
Fondaparinux sodium—Oedema—Epirubicin—pancreatic cancer	0.000416	0.000416	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000416	0.000416	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000415	0.000415	CcSEcCtD
Fondaparinux sodium—Infection—Epirubicin—pancreatic cancer	0.000414	0.000414	CcSEcCtD
Fondaparinux sodium—Cough—Doxorubicin—pancreatic cancer	0.000412	0.000412	CcSEcCtD
Fondaparinux sodium—Shock—Epirubicin—pancreatic cancer	0.00041	0.00041	CcSEcCtD
Fondaparinux sodium—Convulsion—Doxorubicin—pancreatic cancer	0.000409	0.000409	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Epirubicin—pancreatic cancer	0.000408	0.000408	CcSEcCtD
Fondaparinux sodium—Dizziness—Docetaxel—pancreatic cancer	0.000408	0.000408	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000408	0.000408	CcSEcCtD
Fondaparinux sodium—Tachycardia—Epirubicin—pancreatic cancer	0.000406	0.000406	CcSEcCtD
Fondaparinux sodium—Skin disorder—Epirubicin—pancreatic cancer	0.000404	0.000404	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000402	0.000402	CcSEcCtD
Fondaparinux sodium—Chest pain—Doxorubicin—pancreatic cancer	0.000402	0.000402	CcSEcCtD
Fondaparinux sodium—Anxiety—Doxorubicin—pancreatic cancer	0.0004	0.0004	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000399	0.000399	CcSEcCtD
Fondaparinux sodium—Anorexia—Epirubicin—pancreatic cancer	0.000397	0.000397	CcSEcCtD
Fondaparinux sodium—Vomiting—Docetaxel—pancreatic cancer	0.000392	0.000392	CcSEcCtD
Fondaparinux sodium—Rash—Docetaxel—pancreatic cancer	0.000389	0.000389	CcSEcCtD
Fondaparinux sodium—Hypotension—Epirubicin—pancreatic cancer	0.000389	0.000389	CcSEcCtD
Fondaparinux sodium—Dermatitis—Docetaxel—pancreatic cancer	0.000389	0.000389	CcSEcCtD
Fondaparinux sodium—Confusional state—Doxorubicin—pancreatic cancer	0.000388	0.000388	CcSEcCtD
Fondaparinux sodium—Headache—Docetaxel—pancreatic cancer	0.000387	0.000387	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000385	0.000385	CcSEcCtD
Fondaparinux sodium—Oedema—Doxorubicin—pancreatic cancer	0.000385	0.000385	CcSEcCtD
Fondaparinux sodium—Infection—Doxorubicin—pancreatic cancer	0.000383	0.000383	CcSEcCtD
Fondaparinux sodium—Shock—Doxorubicin—pancreatic cancer	0.000379	0.000379	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000378	0.000378	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000377	0.000377	CcSEcCtD
Fondaparinux sodium—Insomnia—Epirubicin—pancreatic cancer	0.000376	0.000376	CcSEcCtD
Fondaparinux sodium—Tachycardia—Doxorubicin—pancreatic cancer	0.000376	0.000376	CcSEcCtD
Fondaparinux sodium—Skin disorder—Doxorubicin—pancreatic cancer	0.000374	0.000374	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Epirubicin—pancreatic cancer	0.000374	0.000374	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000372	0.000372	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Epirubicin—pancreatic cancer	0.000371	0.000371	CcSEcCtD
Fondaparinux sodium—Somnolence—Epirubicin—pancreatic cancer	0.00037	0.00037	CcSEcCtD
Fondaparinux sodium—Anorexia—Doxorubicin—pancreatic cancer	0.000367	0.000367	CcSEcCtD
Fondaparinux sodium—Nausea—Docetaxel—pancreatic cancer	0.000367	0.000367	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Epirubicin—pancreatic cancer	0.000366	0.000366	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Epirubicin—pancreatic cancer	0.000362	0.000362	CcSEcCtD
Fondaparinux sodium—Hypotension—Doxorubicin—pancreatic cancer	0.00036	0.00036	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000359	0.000359	CcSEcCtD
Fondaparinux sodium—Fatigue—Epirubicin—pancreatic cancer	0.000359	0.000359	CcSEcCtD
Fondaparinux sodium—Constipation—Epirubicin—pancreatic cancer	0.000356	0.000356	CcSEcCtD
Fondaparinux sodium—Pain—Epirubicin—pancreatic cancer	0.000356	0.000356	CcSEcCtD
Fondaparinux sodium—Insomnia—Doxorubicin—pancreatic cancer	0.000348	0.000348	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Doxorubicin—pancreatic cancer	0.000346	0.000346	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Doxorubicin—pancreatic cancer	0.000343	0.000343	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Epirubicin—pancreatic cancer	0.000343	0.000343	CcSEcCtD
Fondaparinux sodium—Somnolence—Doxorubicin—pancreatic cancer	0.000342	0.000342	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00034	0.00034	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Doxorubicin—pancreatic cancer	0.000339	0.000339	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Doxorubicin—pancreatic cancer	0.000335	0.000335	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000333	0.000333	CcSEcCtD
Fondaparinux sodium—Fatigue—Doxorubicin—pancreatic cancer	0.000332	0.000332	CcSEcCtD
Fondaparinux sodium—Urticaria—Epirubicin—pancreatic cancer	0.000331	0.000331	CcSEcCtD
Fondaparinux sodium—Pain—Doxorubicin—pancreatic cancer	0.000329	0.000329	CcSEcCtD
Fondaparinux sodium—Constipation—Doxorubicin—pancreatic cancer	0.000329	0.000329	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Epirubicin—pancreatic cancer	0.000329	0.000329	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Epirubicin—pancreatic cancer	0.000329	0.000329	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000317	0.000317	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000315	0.000315	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Epirubicin—pancreatic cancer	0.000307	0.000307	CcSEcCtD
Fondaparinux sodium—Urticaria—Doxorubicin—pancreatic cancer	0.000306	0.000306	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Doxorubicin—pancreatic cancer	0.000304	0.000304	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Doxorubicin—pancreatic cancer	0.000304	0.000304	CcSEcCtD
Fondaparinux sodium—Asthenia—Epirubicin—pancreatic cancer	0.000299	0.000299	CcSEcCtD
Fondaparinux sodium—Pruritus—Epirubicin—pancreatic cancer	0.000294	0.000294	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Epirubicin—pancreatic cancer	0.000285	0.000285	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000284	0.000284	CcSEcCtD
Fondaparinux sodium—Asthenia—Doxorubicin—pancreatic cancer	0.000276	0.000276	CcSEcCtD
Fondaparinux sodium—Dizziness—Epirubicin—pancreatic cancer	0.000275	0.000275	CcSEcCtD
Fondaparinux sodium—Pruritus—Doxorubicin—pancreatic cancer	0.000272	0.000272	CcSEcCtD
Fondaparinux sodium—Vomiting—Epirubicin—pancreatic cancer	0.000265	0.000265	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Doxorubicin—pancreatic cancer	0.000264	0.000264	CcSEcCtD
Fondaparinux sodium—Rash—Epirubicin—pancreatic cancer	0.000262	0.000262	CcSEcCtD
Fondaparinux sodium—Dermatitis—Epirubicin—pancreatic cancer	0.000262	0.000262	CcSEcCtD
Fondaparinux sodium—Headache—Epirubicin—pancreatic cancer	0.000261	0.000261	CcSEcCtD
Fondaparinux sodium—Dizziness—Doxorubicin—pancreatic cancer	0.000255	0.000255	CcSEcCtD
Fondaparinux sodium—Nausea—Epirubicin—pancreatic cancer	0.000247	0.000247	CcSEcCtD
Fondaparinux sodium—Vomiting—Doxorubicin—pancreatic cancer	0.000245	0.000245	CcSEcCtD
Fondaparinux sodium—Rash—Doxorubicin—pancreatic cancer	0.000243	0.000243	CcSEcCtD
Fondaparinux sodium—Dermatitis—Doxorubicin—pancreatic cancer	0.000243	0.000243	CcSEcCtD
Fondaparinux sodium—Headache—Doxorubicin—pancreatic cancer	0.000241	0.000241	CcSEcCtD
Fondaparinux sodium—Nausea—Doxorubicin—pancreatic cancer	0.000229	0.000229	CcSEcCtD
